Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line

Cancer Research

Volumn 57, Issue 10, 1997, Pages 1962-1969

  Lansing, Timothy J ^a   Turk, Bartel F ^a   Kanner, Steven B ^b   Gilmer, Tona M ^a  

^a GLAXOSMITHKLINE   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE P60;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL CLONE; CELL CULTURE; CELL STRAIN 3T3; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; ENZYME ACTIVATION; GENE MUTATION; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CRICETINAE; DNA; MESOCRICETUS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PHENOTYPE; PHOSPHORYLATION; PHOSPHOTYROSINE; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS PP60(C-SRC); TRANSFECTION; TYROSINE;

EID: 0030913477     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Takeya, T., and Hanafusa, H. Structure and sequence of the cellular gene homologous to the Rous sarcoma virus src gene and the mechanism for generating the transforming virus. Cell, 32: 881-890, 1983.
2. c-src. Cell, 37: 131-139, 1984.
3. c-src: implications for regulation. Science (Washington DC), 231: 1431-1434, 1986.
4. c-src with tyrosine kinase activity: the intramolecular pY530-SH2 complex retains significant activity if Y419 is phosphorylated. Biochemistry, 35: 9519-9525, 1996.
5. c-src mutated in the carboxy-terminal regulatory domain. Cell, 49: 83-91, 1987.
6. c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell, 49: 65-73, 1987.
7. c-src. Cell, 49: 75-82, 1987.
8. Reynolds, A. B., Vila, J., Lansing, T. J., Potts, W. M., Weber, M. J., and Parsons, J. T. Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus. EMBO J., 6: 2359-2364, 1987.
9. Cobb, B. S., Payne, D. M., Reynolds, A. B., and Parsons, J. T. Regulation of the oncogenic activity of the cellular src protein requires the correct spacing between the kinase domain and the C-terminal phosphorylated tyrosine (tyr527). Mol. Cell. Biol., 11: 5832-5838, 1991.
10. Johnson, P. J., Cossens, P. M., Danko, A. V., and Shalloway, D. Overexpressed pp60c-src can induce focus formation without complete transformation of NIH 3T3 cells. Mol. Cell. Biol., 5: 1073-1083, 1985.
11. Iba, H., Takeya, T., Cross, F. R., Hanafusa, T., and Hanafusa, H. Rous sarcoma virus variants which carry the cellular src gene instead of the viral src gene cannot transform chicken embryo fibronlasts. Proc. Natl. Acad. Sci. USA, 81: 4424-4428, 1984.
12. Lin, P-H., Shenoy, S., Galitski, T., and Shalloway, D. Transformation of mouse cells by wild-type mouse c-Src. Oncogene, 10: 401-405, 1995.
13. Barrett, J. C., Crawford, B. D., Mixter, L. O., Schechtman, L. M., Ts'o, P. O., and Pollack, R. Correlation of in vitro growth properties and tumorigenicity of Syrian hamster cell lines. Cancer Res., 39: 1504-1510, 1979.
14. c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells. Oncogene, 2: 327-335, 1988.
15. Kanner, S. B., Gilmer, T. M., Reynolds, A. B., and Parsons, J. T. Novel tyrosine phosphorylations accompany the activation of pp60c-src during chemical carcinogenesis. Oncogene, 4: 295-300, 1989.
16. Gilmer, T. M., Annab, L. A., Oshimura, M., and Barrett, J. C. Neoplastic transformation of normal and carcinogen-induced preneoplastic Syrian hamster embryo cells by the v-src oncogene. Mol. Cell. Biol., 5: 1707-1713, 1985.
17. Gilmer, T. M., Lamb, P. A., Oshimura, M., and Barrett, J. C. Correlation of v-src gene amplification with the tumorigenic phenotype in a Syrian hamster embryo cell line. Cancer Res., 47: 4663-4666, 1987.
18. Southern, P. J., and Berg, P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet., 1: 327-341, 1982.
19. Gilmer, T. M., Annab, L. A., and Barrett, J. C. Characterization of activated protooncogenes in chemically transformed Syrian hamster embryo cells. Mol. Carcinog., 1: 180-188, 1988.
20. Merritt, W. D., Weissler, M. C., Turk, B. F., and Gilmer, T. M. Oncogene amplification in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg., 116: 1394-1398, 1990.
21. c-src, in Escherichia coli. Proc. Natl. Acad. Sci. USA, 79: 2152-2156, 1982.
22. Lowry, O. H., Rosebrough, N. J., Farr, A. J., and Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265-275, 1951.
23. src of avian and mammalian origin. J. Virol., 51: 272-282, 1984.
24. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
25. Cleveland, D. W., Fischer, S. G., Kirschner, M. W., and Laemmli, U. K. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J. Biol. Chem., 252: 1102-1106, 1977.
26. Schagger, H., and von Jagow, G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Arch. Biochem., 166: 368-379, 1987.
27. Kanner, S. B., Reynolds, A. B., Vines, R. R., and Parsons, J. T. Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogeneencoded tyrosine kinases. Proc. Natl. Acad. Sci. USA, 87: 3328-3332, 1990.
28. Lipsich, L. A., Lewis, A. J., and Brugge, J. S. Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses. J. Virol., 48: 352-360, 1983.
29. c-src with two major signalling pathways. Proc. Natl. Acad. Sci. USA, 91: 83-87.
30. c-src is associated with altered regulation of adenylyl cyclase. Cell Regul., 4: 531-541, 1992.
31. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
32. Frohman, M. A., Dush, M. K., and Martin, G. R. Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. USA, 85: 8998-9002, 1988.
33. Sanger, F., Nicklen, S., and Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74: 5463-5467, 1977.
34. Cantley, L. C., Auger, K., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R., and Soltoff, S. Oncogenes and signal transduction. Cell, 64: 281-302, 1991.
35. Koch, C. A., Anderson, D., Moran, M. F., Ellis, C., and Pawson, T. SH2 and SH3 domains: elements that control interaction of cytoplasmic signaling molecules. Science (Washington DC), 252: 668-674, 1991.
36. Cooper, J. A., and Howell, B. The when and how of src regulation. Cell, 73: 1051-1054, 1993.
37. Liu, X., Brodeur, S. R., Gish, G., Songyang, Z., Cantley, L. C., Laudano, A. P., and Pawson, T. Regulation of c-Src tyrosine kinase activity by the src SH2 domain. Oncogene, 8: 1119-1126, 1993.
38. Reynolds, A. B., Roesel, D. J., Kanner, S. B., and Parsons, J. T. Transformation-specific tyrosine phosphorylation of a novel cellular protein in chicken cells expressing oncogenic variants of the avian cellular src gene. Mol. Cell. Biol., 9: 629-638, 1989.
39. Reynolds, A. B., Kanner, S. B., Wang, H-C. R., and Parsons, J. T. Stable association of activated pp60src with two tyrosine phosphorylated cellular proteins. Mol. Cell. Biol., 9: 3951-3958, 1989.
40. Parsons, J. T., and Weber, M. J. Genetics of src: structure and functional organization of a protein tyrosine kinase. Curr. Top. Microbiol. Immunol., 147: 79-127, 1989.
41. Laudano, A. P., and Buchanan, J. M. Phosphorylation of tyrosine in the carboxyterminal tryptic peptide of pp60c-src. Proc. Natl. Acad. Sci. USA, 83: 892-896, 1986.
42. MacAuley, A., Okada, M., Nada, S., Nakagawa, H., and Cooper, J. A. Phosphorylation of src mutants at tyr527 in fibroblasts does not correlate with in vitro phosphorylation by CSK. Oncogene, 8: 117-124, 1993.
43. Cheng, S. H., Piwnica-Worms, H., Harvey, R. W., Roberts, T. M., and Smith, A. E. The carboxy terminus of pp60c-src is a regulatory domain and is involved in complex formation with the middle-T antigen of polyomavirus. Mol. Cell. Biol., 8: 1736-1747, 1988.
44. c-src activation in human colon carcinoma. J. Clin. Invest., 83: 2025-2033, 1989.
45. c-src protein kinase is an early event in colonic carcinogenesis. Proc. Natl. Acad. Sci. USA, 87: 558-562.
46. c-src in progressive stages of human colorectal cancer. J. Clin. Invest., 91: 53-60, 1993.
47. Ottenhoff-Kalff, A. E., Rijksen, G., van Beurden, E. A. C. M., Hennipman, A., Michels, A. A., and Staal, G. E. J. Characterization of protein tyrosine kinases from human breast: involvement of the c-src oncogene product. Cancer Res., 52: 4773-4778.